Green Bay Oncology, Ltd. – Trademark Portfolio
Entity Type: 03
Green Bay Oncology, Ltd. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 2 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 3 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include RELENTLESS. The owner is based in Green Bay, WI.
1726 Shawano Avenue
Green Bay, WI 54303
Showing of trademarks Trademarks
Trademark Classifications
Green Bay Oncology, Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Insurance; financial affairs; monetary affairs; real estate affairs
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does Green Bay Oncology, Ltd. have?
Green Bay Oncology, Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 1 cancelled.
What trademark classes does Green Bay Oncology, Ltd. file in?
Green Bay Oncology, Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 36 (Insurance & Financial), Class 45 (Legal & Security Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Green Bay Oncology, Ltd.'s most well-known trademarks?
Green Bay Oncology, Ltd.'s registered trademark portfolio includes well-known marks such as RELENTLESS. These are among 1 currently registered trademark in the portfolio.
What is Green Bay Oncology, Ltd.'s trademark registration success rate?
Green Bay Oncology, Ltd. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.